Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dexlansoprazole
|
| gptkbp:approvalYear |
2009
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A02BC06
|
| gptkbp:brand |
gptkb:dexlansoprazole
|
| gptkbp:contraindication |
hypersensitivity to dexlansoprazole
|
| gptkbp:drugClass |
proton pump inhibitor
|
| gptkbp:form |
delayed-release capsule
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kapidex
|
| gptkbp:marketedAs |
gptkb:Takeda_Pharmaceuticals
|
| gptkbp:renamed |
gptkb:Dexilant
confusion with Casodex |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea abdominal pain flatulence |
| gptkbp:usedFor |
gptkb:erosive_esophagitis
gptkb:gastroesophageal_reflux_disease |
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|